THANGANAGARASAN T | Early-Career Clinical Research in Severe Mental Illness and Neuromodulation | Young Scientist Award

Published on by Neuroscientists

Young Scientist Award

THANGANAGARASAN T
Karpagam Faculty of Medical Science and Research, India

THANGANAGARASAN T
THANGANAGARASAN T
Affiliation Karpagam Faculty of Medical Science and Research
Country India
Subject area Early-Career Clinical Research in Severe Mental Illness and Neuromodulation
Event World Neuroscientists Awards
ORCID 0009-0003-8905-344X

The Young Scientist Award recognizes emerging researchers whose scientific work demonstrates research potential, methodological rigor, and relevance to their respective disciplines. Within neuroscience and clinical research, early-career investigators contribute to the understanding of neurological and psychiatric conditions, the evaluation of therapeutic approaches, and the development of evidence-informed clinical practice. THANGANAGARASAN T, affiliated with Karpagam Faculty of Medical Science and Research in India, is associated with the subject area of early-career clinical research in severe mental illness and neuromodulation. This article presents a structured overview of the research area, relevant scholarly contributions, and the general considerations used when evaluating early-career scientific recognition. Individual publication records, bibliometric indicators, and award outcomes require independent verification before being attributed to the researcher.

Abstract

Early-career research is important to the advancement of neuroscience, psychiatry, and evidence-based clinical care. Severe mental illnesses can involve substantial functional impairment and complex treatment needs, making rigorous clinical investigation and evaluation of therapeutic interventions important areas of scientific inquiry. Neuromodulation research examines approaches that influence neural activity and investigates their potential applications, effectiveness, safety, and limitations. This article outlines the relevance of these research themes to the Young Scientist Award context associated with the World Neuroscientists Awards. It identifies research quality, ethical conduct, transparent reporting, and reproducibility as key considerations for assessing early-career investigators. Specific achievements by THANGANAGARASAN T, including publications, citations, and award status, are not asserted without independently verifiable supporting records. General guidance is informed by established clinical reporting and research-integrity frameworks. [1] [2]

Keywords

Young Scientist Award; neuroscience; early-career researcher; severe mental illness; clinical research; neuromodulation; psychiatric research; evidence-based medicine; clinical trial methodology; research ethics; reproducibility; scientific communication; translational neuroscience; research integrity.

Introduction

Scientific awards can provide a framework for recognizing research promise, professional development, and contributions to a scientific community. In neuroscience, progress frequently depends on collaboration among clinical practitioners, laboratory investigators, statisticians, and specialists in neural measurement and intervention. Research into severe mental illness is particularly important because clinical outcomes can vary across individuals, and treatment decisions often require the careful interpretation of multiple forms of evidence.

Neuromodulation encompasses interventions intended to alter the activity of neural circuits. Depending on the method, research may investigate clinical outcomes, mechanisms of action, treatment tolerability, patient selection, or longer-term effects. Claims about the effectiveness of any intervention must be supported by appropriately designed studies, transparent methods, and balanced interpretation of results. Systematic reviews and clinical practice guidance can help place individual findings within the wider evidence base. [3]

The Young Scientist Award is considered here as a research-recognition topic rather than confirmation of a specific nomination or award decision. The eligibility rules, deadlines, judging procedures, and recipient announcements for the relevant event should be checked against its official information before publication.

Research Profile

THANGANAGARASAN T is identified in the supplied profile information as being affiliated with Karpagam Faculty of Medical Science and Research, India. The stated research subject area is early-career clinical research in severe mental illness and neuromodulation. The ORCID identifier supplied for this profile is 0009-0003-8905-344X. ORCID provides persistent researcher identifiers that can help distinguish individuals and connect their scholarly records. [4]

The supplied information does not independently establish a complete academic biography, clinical specialty, employment history, educational qualifications, research funding, or list of publications. These details should be added only after verification against institutional records, the researcher’s authenticated profile, or primary publication sources.

A comprehensive research profile in this field may include clinical research interests, study design experience, involvement in multidisciplinary research, knowledge of research ethics, and contributions to scholarly dissemination. These are suggested profile elements, not claims that the named researcher has completed specific activities.

Research Contributions

Research on severe mental illness and neuromodulation may address clinically significant questions about symptom improvement, functional recovery, treatment response, adverse effects, and differences in outcomes among patient groups. Contributions can take several forms, including original clinical investigations, systematic reviews, methodological studies, observational research, and collaborative work translating scientific findings into clinical settings.

For a research contribution to be evaluated reliably, the study question and methods should be clearly reported, outcome measures should be appropriate to the research question, and limitations should be acknowledged. Clinical studies should also demonstrate suitable ethical oversight and participant protections. Reporting guidelines such as CONSORT for randomized trials and PRISMA for systematic reviews can improve transparency when applied to the relevant study design. [1] [2]

Potential areas for documenting the researcher’s verified contributions include:

  • Clinical investigation of severe mental illness using clearly defined diagnostic and outcome measures.
  • Evaluation of neuromodulation approaches through suitable clinical or translational research designs.
  • Critical appraisal of published evidence concerning psychiatric treatment effectiveness and safety.
  • Ethical, transparent reporting of clinical methods, results, limitations, and potential conflicts of interest.
  • Collaboration and scientific communication that support reproducibility and responsible interpretation of clinical findings.

These items describe relevant research directions and evaluation criteria. They should not be interpreted as a verified inventory of completed projects or achievements by THANGANAGARASAN T.

Publications

A publication record is an important source of evidence when assessing an early-career researcher’s scholarly activity. Relevant records may include peer-reviewed original research, systematic reviews, conference papers, research protocols, and other scholarly outputs. Each item should be verified using the original publisher’s page, a DOI record, or a recognized bibliographic database.

No publication titles, DOI identifiers, Scopus author identifier, document count, citation count, or h-index were provided in the profile information available for this article. Accordingly, no individual publication is attributed to the researcher here. Bibliometric indicators should be reported only after matching records to the correct researcher and checking for duplicate entries, name ambiguity, and database coverage.

For publication verification, Crossref provides searchable bibliographic metadata and DOI information. [5] Where a DOI is available, the standard resolver format is https://doi.org/ followed by the complete DOI suffix. A specific DOI must not be assigned without confirming the corresponding publication.

Research Impact

The impact of clinical neuroscience research should be evaluated through a combination of scientific quality, relevance to clinical needs, reproducibility, and potential value to patients and healthcare systems. Citation counts may indicate scholarly attention, but they do not independently establish the validity, originality, or practical importance of a study. The interpretation of bibliometric indicators also depends on publication age, subject area, database coverage, and authorship practices.

In severe mental illness and neuromodulation, clinically meaningful impact may involve improved understanding of treatment response, better characterization of risks, identification of unanswered research questions, or evidence that informs future clinical investigations. These outcomes require appropriate supporting evidence and should not be inferred solely from an award nomination or a researcher’s stated subject area.

A balanced impact assessment can consider the following factors:

  • Scientific rigor and suitability of the methods used.
  • Transparency of reporting and availability of relevant supporting information.
  • Clinical relevance and appropriate interpretation of benefits and risks.
  • Independent corroboration, reproducibility, and consistency with existing evidence.
  • Responsible communication of findings to researchers, clinicians, and the public.

Award Suitability

The relevance of a Young Scientist Award to a researcher in clinical neuroscience depends on the event’s published eligibility requirements and assessment criteria. Early-career awards commonly consider factors such as originality, research quality, scholarly contributions, potential for continued development, and relevance to the award’s stated scope. The actual criteria for the World Neuroscientists Awards must be confirmed using official event documentation before any specific eligibility determination is made.

A transparent assessment of suitability may consider the following areas:

  1. Research originality: whether the work addresses a meaningful question or provides a justified contribution to existing knowledge.
  2. Methodological quality: whether the research design, analysis, and reporting are appropriate to the stated objectives.
  3. Scholarly evidence: whether publications, presentations, or other outputs can be independently verified.
  4. Ethical responsibility: whether relevant approvals, consent procedures, and participant safeguards are documented when applicable.
  5. Research development: whether the applicant demonstrates a credible trajectory of learning, collaboration, and scientific contribution.
  6. Eligibility compliance: whether the applicant satisfies the event’s specified career-stage, documentation, submission, and deadline requirements.

The stated subject area of THANGANAGARASAN T is relevant to neuroscience and clinical research in general. However, this alone does not establish eligibility, nomination, selection, or receipt of an award. Any public statement about award status should be supported by an official announcement or direct confirmation from the organizer.

Conclusion

The Young Scientist Award provides a useful framework for discussing the recognition of emerging scientific researchers and the qualities associated with responsible early-career research. Severe mental illness and neuromodulation represent important areas of clinical neuroscience in which rigorous study design, ethical conduct, transparent reporting, and evidence-based interpretation are essential. THANGANAGARASAN T is identified in the supplied information as affiliated with Karpagam Faculty of Medical Science and Research in India, with a stated subject area in early-career clinical research in severe mental illness and neuromodulation.

Further development of this article should include independently verified biographical details, publication records, research outputs, and official award information where available. Maintaining a clear distinction between verified facts, general disciplinary context, and unconfirmed claims supports accuracy and scholarly credibility.

References

The following sources provide methodological, reporting, and researcher-identification context for this article. They do not independently establish the named researcher’s publication record or award status.

  1. Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ, 340, c332. https://doi.org/10.1136/bmj.c332
  2. Page, M. J., McKenzie, J. E., Bossuyt, P. M., et al. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
  3. National Institute for Health and Care Excellence. (n.d.). Guidance and evidence on mental health and neurological conditions. NICE. https://www.nice.org.uk/guidance
  4. ORCID. (n.d.). ORCID: Connecting research and researchers. https://orcid.org/
  5. Crossref. (n.d.). Crossref metadata search. Crossref. https://search.crossref.org/

Editorial note: This page is an informational academic profile based on the supplied details and general scholarly references. Bibliometric values, individual research achievements, nomination status, and award outcomes have not been independently verified. Confirm all researcher-specific claims and event details before presenting the page as an authoritative biography.

John Dowling | Photoreceptor and Retinal Studies | Innovative Research Award

Published on by Neuroscientists

Innovative Research Award

John E. Dowling — Harvard University, United States

John E. Dowling
Affiliation Harvard University
Country United States
Scopus ID 15051769000
Documents 275
Citations 20,874
h-index 85
Subject Area Photoreceptor and retinal studies
Event World Neuroscientists Awards
ORCID 0000-0002-8441-6761

John E. Dowling is a neuroscientist associated with Harvard University’s Department of Molecular and Cellular Biology and is identified by the university as Gordon and Llura Gund Professor of Neurosciences, Emeritus. His research has centered on the vertebrate retina as an experimentally accessible component of the central nervous system, with particular attention to retinal cell structure, physiology, synaptic organization, pharmacology, development, genetics, photoreceptor biology, and visual information processing. His more recent work has also incorporated connectomic approaches for reconstructing retinal circuitry and examining retinal disease. [1]

*Publication and citation figures shown in the infobox correspond to publicly reported scholarly-profile metrics and should not be interpreted as independently verified current Scopus totals. Bibliometric databases may differ in coverage, document counting, citation indexing, and author-profile consolidation. [8]

Abstract

John E. Dowling’s research career has addressed fundamental questions concerning how retinal neurons receive, transform, modulate, and transmit visual information. The retina has served in his work as a model neural system for investigating mechanisms that are relevant to the wider central nervous system. His scientific record includes studies of photoreceptor adaptation, retinal degeneration, neurotransmission and neuromodulation, retinoic-acid-dependent photoreceptor development, retinal circuitry, and ultrastructural connectomics. [1] [2] [3]

This article evaluates his research profile in relation to the Innovative Research Award of the World Neuroscientists Awards. The assessment is framed as an academic recognition profile rather than as an independent award decision and considers originality of research questions, methodological development, continuity of scientific contribution, translational relevance, and influence on the understanding of retinal and neural organization.

Keywords

Retina; Photoreceptors; Retinal circuitry; Visual neuroscience; Rod cells; Cone cells; Synaptic interactions; Neuromodulation; Dopamine; Retinoic acid; Retinal degeneration; Connectomics; Fovea; Visual processing; Neural organization; Photoreceptor development; Macular disease; Ultrastructure; Vision science; Neurobiology.

Introduction

The vertebrate retina is a highly organized neural tissue in which photoreceptors initiate the conversion of light into neural signals and interconnected retinal neurons progressively transform those signals before information leaves the eye through retinal ganglion-cell axons. Because its cellular organization and synaptic architecture can be studied experimentally with considerable precision, the retina has historically provided an important framework for understanding general principles of neural processing. Dowling’s research program adopted this conceptual framework and investigated retinal cells at structural, physiological, pharmacological, genetic, and circuit levels. [1]

His work spans several periods in modern visual neuroscience. Earlier research addressed photoreceptor adaptation and inherited retinal degeneration, whereas subsequent investigations examined developmental signaling, retinal neuromodulation, and the organization of retinal networks. More recent studies have applied high-resolution connectomic methodologies to disease-associated retinal tissue and to questions concerning the organization of the human fovea. [2] [3] [4]

Research Profile

Dowling is listed by Harvard University’s Department of Molecular and Cellular Biology as Gordon and Llura Gund Professor of Neurosciences, Emeritus. Harvard describes his research as focusing on the cells of the vertebrate retina, including their structure, function, pharmacology, genetics, synaptic interactions, and functional organization. The university also identifies ongoing collaborative work involving connectomic reconstruction of the human fovea. [1]

  • Primary discipline: Neuroscience and vision science.
  • Core research system: Vertebrate retina and its neuronal circuitry.
  • Cellular focus: Rod and cone photoreceptors, horizontal cells, interneurons, and retinal network organization.
  • Mechanistic themes: Phototransduction-related adaptation, neurotransmission, neuromodulation, development, degeneration, and synaptic connectivity.
  • Methodological themes: Morphological analysis, physiological investigation, developmental experimentation, molecular approaches, and ultrastructural connectomics.
  • Current scholarly context: Retinal connectomics, human foveal reconstruction, retinal disease, and unresolved questions in retinal organization. [1] [7]

Research Contributions

Photoreceptor physiology and adaptation. Dowling’s earlier physiological research contributed to experimental characterization of how vertebrate photoreceptors change their responsiveness under different illumination conditions. A study of skate photoreceptors with Harris Ripps examined mechanisms of photoreceptor adaptation and remains part of the historical literature concerning cellular responses to changing light conditions. [2]

Inherited retinal degeneration. Work with Richard L. Sidman investigated inherited retinal dystrophy in the rat using morphological and cellular approaches. Such research helped establish experimental retinal degeneration as a tractable model for examining progressive cellular abnormalities in photoreceptors and associated retinal structures. [3]

Photoreceptor development and retinoic acid. Research involving zebrafish demonstrated that exogenous retinoic acid could alter the timing and pattern of photoreceptor differentiation, accelerating aspects of rod development while influencing cone maturation. The findings provided evidence that retinoid signaling participates in developmental regulation of photoreceptor populations. [4]

Retinal neuromodulation. Dowling’s work has also contributed to understanding how modulatory substances modify retinal signaling. A later review with Douglas G. McMahon discussed the actions of dopamine, retinoic acid, nitric oxide, and additional substances on retinal horizontal cells, situating retinal modulation within broader principles of nervous-system regulation. [5]

Connectomics and retinal disease. More recent research has used ultrastructural connectomic approaches to examine retinal disease. A 2020 study involving Dowling and collaborators analyzed retinal tissue associated with macular telangiectasia and demonstrated how detailed reconstruction of neural tissue can reveal disease-related alterations at cellular and circuit levels. [6]

Contemporary retinal questions. In 2026, Dowling, Frank S. Werblin, and Samuel M. Wu published a review addressing unresolved questions in retinal research, demonstrating continuing engagement with conceptual problems in visual neuroscience and identifying areas in which retinal structure and function remain incompletely understood. [7]

Publications

Dowling’s publication record includes experimental articles, reviews, scholarly books, and interdisciplinary treatments of retinal and neural function. Representative works illustrating the development of his research program include:

  • Dowling, J. E., & Sidman, R. L. (1962). Inherited retinal dystrophy in the rat. Journal of Cell Biology, 14(1), 73–109.
    DOI: https://doi.org/10.1083/jcb.14.1.73
  • Dowling, J. E., & Ripps, H. (1972). Adaptation in skate photoreceptors. Journal of General Physiology, 60(6), 698–719.
    DOI: https://doi.org/10.1085/jgp.60.6.698
  • Hyatt, G. A., Schmitt, E. A., Fadool, J. M., & Dowling, J. E. (1996). Retinoic acid alters photoreceptor development in vivo. Proceedings of the National Academy of Sciences, 93(23), 13298–13303.
    DOI: https://doi.org/10.1073/pnas.93.23.13298
  • Dowling, J. E. (2012). The Retina: An Approachable Part of the Brain, Revised Edition. Harvard University Press.
    DOI: https://doi.org/10.2307/j.ctv31zqj2d
  • Zucker, C. L., Bernstein, P. S., Schalek, R. L., Lichtman, J. W., & Dowling, J. E. (2020). A connectomics approach to understanding a retinal disease. Proceedings of the National Academy of Sciences, 117(31), 18780–18787.
    DOI: https://doi.org/10.1073/pnas.2011532117
  • McMahon, D. G., & Dowling, J. E. (2023). Neuromodulation: Actions of dopamine, retinoic acid, nitric oxide, and other substances on retinal horizontal cells. Eye and Brain, 15, 125–137.
    DOI: https://doi.org/10.2147/EB.S420050
  • Dowling, J. E., Werblin, F. S., & Wu, S. M. (2026). Unsolved retinal questions. Progress in Retinal and Eye Research, 112, 101450.
    DOI: https://doi.org/10.1016/j.preteyeres.2026.101450

Research Impact

The impact of Dowling’s research is observable in several complementary dimensions. His work links cellular neurobiology with systems-level questions of visual processing, providing a research trajectory that moves from photoreceptor physiology and retinal morphology to developmental signaling, neuromodulation, degeneration, and connectomic reconstruction. His book The Retina: An Approachable Part of the Brain further synthesized retinal structure and function as a framework for understanding nervous-system organization. [9]

Publicly available scholarly-profile data report a substantial publication and citation record for Dowling in neuroscience. Such metrics provide an indication of the visibility and uptake of his work, although exact totals may vary significantly among Scopus, Web of Science, Google Scholar, and independent bibliometric services because of differences in database coverage and author disambiguation. For this reason, numerical metrics are best interpreted alongside the longevity, methodological diversity, and disciplinary relevance of the underlying publications. [8]

An additional indicator of continuing research relevance is the transition of his work into modern connectomics. Harvard reports that Dowling has collaborated on reconstruction of the human fovea using high-resolution sectioning and imaging approaches developed for neural connectomics, while disease-oriented studies have applied related methods to retinal degeneration and macular pathology. [1] [6]

Award Suitability

In the context of an Innovative Research Award, Dowling’s research record can be assessed according to scientific originality, methodological adaptation, durability of contribution, and relevance to contemporary neuroscience. The suitability discussion below represents an evidence-based academic interpretation of publicly documented research and does not constitute an official decision by the World Neuroscientists Awards.

  • Scientific originality: His work has addressed retinal function through physiological, structural, pharmacological, developmental, genetic, and circuit-level perspectives rather than through a single methodological framework. [1]
  • Methodological innovation: The incorporation of ultrastructural connectomics into retinal and disease research illustrates adaptation to modern high-resolution approaches for analyzing neural circuits. [6]
  • Foundational relevance: Studies of photoreceptor adaptation, retinal degeneration, and developmental signaling address processes fundamental to sensory neuroscience and retinal biology. [2] [3] [4]
  • Translational connection: Connectomic investigation of diseased human retinal tissue provides a direct link between basic circuit neuroscience and disorders affecting vision. [6]
  • Continuity of scholarship: Publications extending from classical retinal physiology to a 2026 review of unresolved retinal questions demonstrate sustained engagement with evolving problems in the field. [2] [7]
  • Educational and conceptual influence: Scholarly books, particularly The Retina: An Approachable Part of the Brain, have contributed to the broader conceptual presentation of the retina as a model for studying neural organization. [9]

Collectively, these characteristics establish a substantial academic basis for considering Dowling within an innovation-oriented neuroscience recognition framework, particularly in categories emphasizing retinal neuroscience, photoreceptor biology, neural circuitry, visual processing, and connectomic investigation.

Conclusion

John E. Dowling’s research profile reflects a long-term scientific focus on understanding how retinal cells and neural circuits generate, regulate, and preserve visual function. His contributions encompass photoreceptor adaptation, retinal dystrophy, developmental regulation, neuromodulatory signaling, retinal organization, disease-related circuitry, and connectomic reconstruction. This breadth is unified by a consistent use of the retina as a model through which broader principles of nervous-system structure and function can be investigated. [1]

Within the scope of the Innovative Research Award at the World Neuroscientists Awards, the available scholarly record demonstrates characteristics relevant to innovation-based academic recognition: development of experimentally grounded insights, adoption of new investigative methods, translation of fundamental neuroscience into disease-oriented research, and sustained contribution to visual neuroscience. Final award determination, however, should incorporate verified bibliometric records, formal nomination materials, eligibility requirements, peer assessment, and the event’s established evaluation procedures.

References

  • Harvard University, Department of Molecular and Cellular Biology. (n.d.). John Dowling — Gordon and Llura Gund Professor of Neurosciences, Emeritus.
    https://www.mcb.harvard.edu/directory/john-dowling/
  • Dowling, J. E., & Ripps, H. (1972). Adaptation in skate photoreceptors. Journal of General Physiology, 60(6), 698–719.
    DOI: https://doi.org/10.1085/jgp.60.6.698
  • Dowling, J. E., & Sidman, R. L. (1962). Inherited retinal dystrophy in the rat. Journal of Cell Biology, 14(1), 73–109.
    DOI: https://doi.org/10.1083/jcb.14.1.73
  • Hyatt, G. A., Schmitt, E. A., Fadool, J. M., & Dowling, J. E. (1996). Retinoic acid alters photoreceptor development in vivo. Proceedings of the National Academy of Sciences, 93(23), 13298–13303.
    DOI: https://doi.org/10.1073/pnas.93.23.13298
  • McMahon, D. G., & Dowling, J. E. (2023). Neuromodulation: Actions of dopamine, retinoic acid, nitric oxide, and other substances on retinal horizontal cells. Eye and Brain, 15, 125–137.
    DOI: https://doi.org/10.2147/EB.S420050

Panagiota Voskou | Cognitive Neuroscience | Innovative Research Award

Published on by Neuroscientists

Innovative Research Award

Panagiota Voskou
National and Kapodistrian University of Athens, Greece
Panagiota Voskou
Affiliation National and Kapodistrian University of Athens
Country Greece
Scopus ID 57046080700
Documents 14
Citations 147
h-index 8
Subject Area Neurology, Dementia, Neuropsychology, Legal Capacity, Cognitive Neuroscience
Event World Neuroscientists Awards
ORCID 0000-0002-2690-0408

Panagiota Voskou is a Greek neurologist, researcher, educator, and postdoctoral candidate affiliated with the National and Kapodistrian University of Athens. Her academic and clinical career has focused extensively on dementia, medico-legal neurology, neuropsychological assessment, and legal capacity evaluation in neurodegenerative disorders. She is internationally recognized for the development and validation of the Testamentary Capacity Assessment Tool (TCAT), a specialized instrument designed for assessing testamentary capacity in patients with dementia and cognitive disorders.[1]

Abstract

This article presents the academic achievements, clinical expertise, and scientific contributions of Panagiota Voskou in the fields of neurology, dementia research, and neuropsychological assessment. Her work integrates clinical neuroscience with medico-legal evaluation, particularly focusing on testamentary capacity and cognitive competence in dementia. Through the development of the Testamentary Capacity Assessment Tool (TCAT), Dr. Voskou has contributed substantially to the advancement of structured legal-capacity assessment methodologies in neurodegenerative disorders. Her publications, conference presentations, educational activities, and international collaborations demonstrate an interdisciplinary approach combining neurology, psychiatry, geriatrics, and forensic medicine.[2]

Keywords

  • Neurology
  • Dementia
  • Neuropsychological Assessment
  • Testamentary Capacity
  • Legal Capacity
  • Cognitive Disorders
  • Alzheimer Disease
  • Movement Disorders
  • Clinical Neuroscience
  • Forensic Psychiatry

Introduction

The increasing prevalence of dementia and cognitive disorders worldwide has highlighted the importance of reliable clinical and medico-legal assessment methodologies. In this context, Panagiota Voskou has emerged as a prominent researcher specializing in the intersection between neurology and legal medicine. Her scientific work addresses the evaluation of cognitive competence, legal capacity, and neuropsychological functioning in individuals with neurodegenerative diseases.[3]

Voskou’s research activities include studies on dementia progression, neuropsychological predictors, migraine-associated disorders, neurodegeneration, and legal capacity assessment. She has participated extensively in international conferences organized by the European Academy of Neurology (EAN), Alzheimer’s Association International Conference (AAIC), World Congress of Neurology (WCN), and other scientific organizations dedicated to neuroscience and geriatric medicine.[4]

Research Profile

Voskou graduated from the Medical School of the National and Kapodistrian University of Athens with distinction and subsequently completed postgraduate and doctoral studies in mental health and dementia-related legal capacity assessment. She currently serves as a Specialist Neurologist at the General Hospital of Chalkida and continues her postdoctoral research on the validation of the Testamentary Capacity Assessment Tool within the Greek population.[5]

Her professional experience spans neurology, psychiatry, internal medicine, pediatric neurology, cognitive disorders, and forensic psychiatry. Voskou has also contributed significantly to medical education through postgraduate teaching programs, webinars, continuing education initiatives, and university-level e-learning activities related to medico-legal issues in dementia.[2]

Research Contributions

One of Voskou’s most notable scientific contributions is the development and validation of the Testamentary Capacity Assessment Tool (TCAT), which provides clinicians with a structured framework for evaluating testamentary competence in patients with dementia and cognitive decline.[1]

Her research contributions also include investigations into mild cognitive impairment, progression to Alzheimer disease or Lewy body dementia, headache disorders, migraine pathophysiology, movement disorders, stroke-related cognitive dysfunction, and legal implications of neurological disease.[3]

  • Development of TCAT for dementia-related legal assessment
  • Research on legal capacity in neurological diseases
  • Neuropsychological predictors in cognitive impairment
  • Migraine and neurodegenerative disease studies
  • Educational contributions in psychogeriatrics and neurology
  • Reviewer activities for international scientific journals

Publications

Voskou has authored and co-authored numerous peer-reviewed scientific publications indexed in internationally recognized databases including Scopus, Web of Science, and PubMed. Her work has appeared in journals related to neurology, geriatrics, psychiatry, neuropsychology, and dementia research.[4]

  1. “Testamentary Capacity Assessment Tool (TCAT): A Brief Instrument for Patients with Dementia.” Journal of Alzheimer’s Disease.
  2. “Testamentary Capacity Assessment: Legal, Medical, and Neuropsychological Issues.” Journal of Geriatric Psychiatry and Neurology.
  3. “Salivary inflammatory markers in tension type headache and migraine: the SalHead cohort study.” Neurological Sciences.
  4. “State-of-the-Art Testamentary Capacity Assessment Tool (TCAT) in Dementia: A Review of Studies and Update Report.” Journal of Dementia and Alzheimer’s Disease.

Research Impact

The impact of Voskou’s work extends across clinical neurology, forensic psychiatry, geriatric medicine, and legal neuropsychology. Her TCAT framework has contributed to improved methodologies for evaluating testamentary competence and cognitive legal decision-making in dementia patients.[1]

Through her presentations at major international congresses, Voskou has promoted interdisciplinary dialogue on legal capacity assessment, neurodegenerative disease management, and ethical considerations in neurological care. Her involvement in educational programs and reviewer responsibilities further demonstrates her contribution to the scientific and academic community.[1]

Award Suitability

Panagiota Voskou demonstrates strong suitability for the Innovative Research Award due to her interdisciplinary scientific achievements and her pioneering contributions to medico-legal neurology. The development of the Testamentary Capacity Assessment Tool represents a clinically relevant innovation with applications in dementia evaluation, legal medicine, and neuropsychological assessment.[2]

Her academic productivity, international conference participation, educational leadership, and peer-reviewed publications collectively support her recognition within the global neuroscience research community. The integration of neuroscience and legal assessment in her work highlights a specialized area of innovation with growing relevance in aging populations and cognitive healthcare systems worldwide.[3]

Conclusion

Panagiota Voskou has established a distinguished academic and clinical profile in neurology, dementia research, and legal neuropsychology. Her scientific contributions, particularly in testamentary capacity assessment, represent meaningful advancements within the interdisciplinary fields of cognitive neuroscience and medico-legal evaluation. Through sustained research activity, international collaboration, teaching, and publication, she continues to contribute to the development of evidence-based neurological assessment methodologies and dementia care practices.[4]

References

  1. Voskou, P., et al. (2018). Testamentary Capacity Assessment Tool (TCAT): A Brief Instrument for Patients with Dementia. Journal of Alzheimer’s Disease.
    https://doi.org/10.3233/JAD-170297
  2. Voskou, P., Douzenis, A., Economou, A., Papageorgiou, S.G. (2026). State-of-the-Art Testamentary Capacity Assessment Tool (TCAT) in Dementia.
    https://doi.org/10.3390/jdad3020025
  3. Voskou, P., et al. (2018). Testamentary Capacity Assessment: Legal, Medical, and Neuropsychological Issues.
    https://doi.org/10.1177/0891988717746508
  4. European Academy of Neurology. (2025). Congress participation records and scientific presentations.
  5. National and Kapodistrian University of Athens. (2025). Official Postdoctoral Certification

Vijaya Narne | Behavioral Neuroscience | Best Researcher Award

Published on by Neuroscientists

Best Researcher Award

Vijaya Narne
Affiliation King Khalid University
Country Saudi Arabia / India
Scopus ID 23103700400
Documents 41
Citations 418
h-index 11
Subject Area Audiology, Hearing Sciences, Auditory Neuroscience, Behavioral Neuroscience
Event World Neuroscientists Awards
ORCID 0000-0002-6531-8015

Vijaya Narne
King Khalid University, Saudi Arabia

Vijaya Narne, is an internationally recognized researcher and academician in the field of audiology and hearing sciences. His research contributions encompass auditory perception, psychoacoustics, electrophysiology, speech perception in noise, hearing impairment diagnostics, auditory processing disorders, and language-specific rehabilitation tools. Over the course of his academic and research career, he has contributed extensively to the advancement of hearing science through interdisciplinary collaborations, novel diagnostic developments, and translational clinical research initiatives.[1]

Abstract

This article presents a scholarly overview of the academic achievements, scientific contributions, and professional accomplishments of Vijaya Kumar Narne in the field of audiology and hearing sciences. His multidisciplinary research has significantly contributed to the understanding of auditory perception, auditory neuropathy spectrum disorders, psychoacoustic modeling, hearing aid rehabilitation, electrophysiology, and language-specific diagnostic methodologies. Through numerous peer-reviewed publications, funded research projects, and collaborative international investigations, Narne has demonstrated sustained contributions toward evidence-based hearing healthcare and auditory science innovation.[2]

Keywords

Audiology, Hearing Sciences, Auditory Neuroscience, Psychoacoustics, Auditory Processing Disorders, Hearing Rehabilitation, Speech Perception, Electrophysiology, Auditory Neuropathy, Hearing Aid Research, Auditory Stream Segregation, Clinical Audiology, Speech-in-Noise Testing, Hearing Diagnostics, Language-Specific Audiology.

Introduction

The discipline of audiology has experienced substantial advancements over recent decades due to innovations in auditory neuroscience, psychoacoustics, electrophysiology, and digital hearing technologies. Within this evolving scientific landscape, researchers who bridge clinical practice with experimental research play an essential role in improving hearing healthcare outcomes. Vijaya Kumar Narne has emerged as a prominent contributor in these domains through his extensive research on auditory processing, hearing impairment diagnostics, and auditory rehabilitation systems.[3]

His academic journey spans leading institutions including the All India Institute of Speech and Hearing, Macquarie University, South Denmark University, Indian Institute of Technology Kanpur, and King Khalid University. These affiliations have enabled international collaborative research in auditory modeling, speech perception, electrophysiological assessment, and hearing aid rehabilitation methodologies.[4]

Research Profile

Narne completed in Audiology at the All India Institute of Speech and Hearing, Mysore, India, where his doctoral research investigated speech perception with spectral and temporal modifications in individuals with auditory dyssynchrony. His work established a strong scientific foundation in auditory processing mechanisms and hearing perception disorders.[5]

Over the course of his academic career, Narne has held several major research and teaching positions internationally. His expertise spans auditory perception modeling, psychoacoustics, hearing aid rehabilitation, auditory electrophysiology, and language-specific auditory diagnostics. He has supervised postgraduate dissertations, collaborated in multidisciplinary research teams, and contributed toward the development of clinically applicable diagnostic protocols and rehabilitation tools.[5]

  • Assistant Professor in Audiology at King Khalid University, Saudi Arabia
  • Senior Project Scientist at Indian Institute of Technology Kanpur
  • Postdoctoral Fellow at South Denmark University
  • Lecturer and Reader at All India Institute of Speech and Hearing
  • Research Audiologist at Macquarie University, Australia

Research Contributions

Narne’s scientific contributions are characterized by interdisciplinary integration between psychoacoustics, auditory neuroscience, hearing diagnostics, and clinical rehabilitation systems. His work on spectral ripple discrimination and spectro-temporal ripple testing has significantly contributed to understanding auditory frequency selectivity and speech perception in noise.[1]

He has also contributed extensively to the development of language-specific speech perception tests and auditory diagnostic tools for multiple Indian languages including Kannada, Malayalam, Telugu, and Hindi. These developments have improved accessibility and reliability of hearing assessments for linguistically diverse populations.[2]

Additionally, his research has advanced the understanding of auditory stream segregation, hearing aid outcomes, cortical auditory evoked potentials, and auditory processing disorders. Several of his projects received support from major funding bodies including ICMR, DST, AIISH, and international hearing research collaborations.[5]

Publications

Narne has authored and co-authored numerous publications in internationally recognized journals specializing in audiology, hearing science, auditory neuroscience, and speech-language pathology. His studies are widely cited in areas related to auditory perception, hearing diagnostics, and speech processing.[1]

  • Narne, V. K., & Moore, B. C. J. (2020). Narrow-band ripple glide discrimination and frequency selectivity. Hearing Research.
  • Narne, V. K. (2013). Temporal processing and speech perception in noise by listeners with auditory neuropathy. PLoS One.
  • Jain, S., Narne, V. K., & Moore, B. C. J. (2022). High-frequency hearing sensitivity and auditory stream segregation. Journal of the Acoustical Society of America.
  • Peter, V., Narne, V. K., Purdy, S. C., & McMahon, C. (2014). Assessing spectral and temporal processing using ripple-based measures. Journal of the American Academy of Audiology.
  • Narne, V. K., & Vanaja, C. S. (2008). Speech identification and cortical potentials in individuals with auditory neuropathy. Behavioral and Brain Functions.

Research Impact

The research impact of Narne extends across clinical audiology, auditory neuroscience, speech perception research, and hearing rehabilitation technologies. His investigations into psychoacoustic processing and auditory stream segregation have provided clinically relevant insights into speech recognition challenges experienced by hearing-impaired populations.[1]

His collaborative international studies with researchers including Prof. Brian C. J. Moore have contributed to the development of advanced auditory assessment methodologies and psychoacoustic-inspired hearing evaluation systems. Furthermore, his work in hearing aid outcome prediction and hearing rehabilitation databases has strengthened evidence-based audiological care frameworks.[2]

Award Suitability

Vijaya Kumar Narne demonstrates strong suitability for recognition in the field of audiology and hearing sciences due to his sustained academic excellence, internationally collaborative research, interdisciplinary innovation, and commitment to clinical translation. His contributions span fundamental auditory science, hearing disorder diagnostics, language-specific rehabilitation tools, and evidence-based clinical methodologies.[3]

His achievements in funded research, peer-reviewed scholarship, postgraduate mentorship, software development, and auditory diagnostic innovation collectively establish a significant academic profile aligned with global standards of scientific excellence and healthcare research advancement.

Conclusion

Vijaya Kumar Narne has established an influential academic and research career within the field of audiology and hearing sciences. His interdisciplinary investigations, clinical innovations, and international collaborations have advanced scientific understanding of auditory processing, hearing rehabilitation, and psychoacoustic diagnostics. Through sustained research productivity, mentorship, and translational scientific contributions, he continues to contribute meaningfully toward global hearing healthcare research and auditory science development.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Vijaya Kumar Narne, Author ID 23103700400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=23103700400
  2. ORCID. (n.d.). Vijaya Kumar Narne Research Profile.
    https://orcid.org/0000-0002-6531-8015
  3. Narne, V. K. (2013). Temporal processing and speech perception in noise by listeners with auditory neuropathy. PLoS One.
    https://doi.org/10.1371/journal.pone.0055995
  4. Narne, V. K., & Moore, B. C. J. (2020). Narrow-band ripple glide discrimination and frequency selectivity. Hearing Research.
    https://doi.org/10.1016/j.heares.2020.107910
  5. Jain, S., Narne, V. K., & Moore, B. C. J. (2022). High-frequency hearing sensitivity and auditory stream segregation. Journal of the Acoustical Society of America.
    https://doi.org/10.1121/10.0012917